Withdrawal of statins in patients with acute coronary syndromes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Perioperative use of statins in noncardiac surgery.Vascular health and risk management · 2008
   Pooled it
2. Effects of different statins application methods on plaques in patients with coronary atherosclerosis.World journal of clinical cases · 2021
   Article
3. Long-Term Benefit and Withdrawal Effect of Statins After Percutaneous Coronary Intervention: A Nationwide Population-Based Cohort Study.Patient preference and adherence · 2020
   Article
4. Drug discontinuation effects are part of the pharmacology of a drug.The Journal of pharmacology and experimental therapeutics · 2011
   Article
5. Statin rebound or withdrawal syndrome: does it exist?Current atherosclerosis reports · 2011 · on this map
   Review
6. Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.Texas Heart Institute journal · 2011
   Article
7. Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery.Current treatment options in cardiovascular medicine · 2009
   Article
8. The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes.Current cardiology reports · 2004
   Review
9. Strategies to increase HMG-CoA reductase inhibitor use after acute myocardial infarction.Drugs & aging · 2004
   Review
10. Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin.Drug safety · 2004
    Article
11. The cardioprotective effects of statins.Current atherosclerosis reports · 2004
    Review
12. A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease.Current controlled trials in cardiovascular medicine · 2001
    Article

Corrections and comments

• Comment on
  Withdrawal of statins increases event rates in patients with acute coronary syndromes.2002

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as